secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001493152-26-010080
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics files prospectus supplement for ATM offering of up to $1.064M in common stock
--------------------------------------------------------------------------------

- Filing covers up to $1,064,000 shares of common stock sold at market through H.C. Wainwright as sales agent.
- Company previously sold $1.7M under prior shelf; new supplement uses Form S-3 declared effective Sept 2025.
- Proceeds from ATM offering will be used for general corporate purposes (not specified further).
- Legal opinion of Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226010080/0001493152-26-010080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226010080/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer